SCHEMBL6137719

SCHEMBL6137719

CC(C)(C)OC(=O)N1C(=O)C2(F)CCCC2c2cc(Cl)ccc21

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
ALDH1A1 P00352 1/20 0.38
HRH3 Q9Y5N1 4/20 0.37
USP30 Q70CQ3 1/20 0.36
PAK1 Q13153 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CNR1 P21554 2/20 0.35
CNR2 P34972 2/20 0.35
MAPK8 P45983 2/20 0.34
OXTR P30559 1/20 0.34
AVPR1A P37288 1/20 0.34
CASP1 P29466 1/20 0.34
STS P08842 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP3A5 P20815 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137319 0.88 HRH3 (0.37) ALDH1A1HRH3USP30KMT2ACASP1
SCHEMBL6137766 0.85 BCHE (0.41) NOS3NOS1NOS2HRH3MEN1
SCHEMBL6137657 0.76 NOS3 (0.41) NOS3NOS1NOS2HRH3MEN1
SCHEMBL6137757 0.76 GPR119 (0.41) ALDH1A1USP30MEN1KMT2A
SCHEMBL6137803 0.74 ALDH1A1 (0.39) ALDH1A1USP30MEN1KMT2ACNR1
SCHEMBL6137770 0.74 NOS3 (0.35) NOS3NOS1NOS2CNR1CNR2
SCHEMBL6137628 0.73 NOS3 (0.34) NOS3NOS1NOS2CNR1CNR2
SCHEMBL31499323 0.70 BCHE (0.40) MEN1KMT2A
SCHEMBL23959005 0.69 BCHE (0.40) MEN1KMT2AAVPR1ASTS
SCHEMBL22871308 0.68 KDM1A (0.43) ALDH1A1USP30PAK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed
EP-1129077-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2001-09-05 EP disclosed
WO-2000029381-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-25 WO disclosed